Tivity Health Inc (TVTY) Received its Third Buy in a Row


After Cantor Fitzgerald and Oppenheimer gave Tivity Health Inc (NASDAQ: TVTY) a Buy rating last month, the company received another Buy, this time from Barrington. Analyst Michael Petusky maintained a Buy rating on Tivity Health Inc today and set a price target of $50. The company’s shares opened today at $34.65.

Petusky wrote:

“We expect a slight acceleration of revenue growth for the remainder of the year as a few of the company’s various growth initiatives begin to have an impact.”

According to TipRanks.com, Petusky is a 4-star analyst with an average return of 16.0% and a 62.9% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Varian Medical Systems, and Merit Medical Systems.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tivity Health Inc with a $45 average price target, representing a 29.9% upside. In a report released yesterday, Cantor Fitzgerald also maintained a Buy rating on the stock with a $49 price target.

.

See today’s analyst top recommended stocks >>

Tivity Health Inc’s market cap is currently $1.35B and has a P/E ratio of 22.65. The company has a Price to Book ratio of 4.59.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Tivity Health, Inc. engages in the development and provision of network solutions and health management services. It offers rehabilitative therapy, chiropractic procedure, alternative medicines, and health and fitness programs under the SilverSneakers, Prime Fitness, and WholeHealth Living trademarks.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts